65,437 trials
Pneumococcal Vaccines
Primary: Percentage of Participants Achieving a Serotype-Specific Pneumococcal Immunoglobulin G (IgG) Antibody Concentration Greater Than or Equal To (>=) 0.35 Microgram Per…
Vision
Primary: Change From Baseline in Color Vision Discrimination 1 Hour Post Dosing — 0.1; -0.4; -0.2; -0.5 total error score — p=0.8216
Weight · Physical Activity
Primary: BMI — 35.1; 33.9 kg/m2
Refractory Multiple Myeloma
Primary: Overall Response Rate (ORR) — 4; 7; 5 participants
Down Syndrome
Primary: Vineland Adaptive Behavior Scales, Second Edition (Survey Interview Form) — -1.7; 2.0 units on a scale
Coronary Atherosclerosis · Coronary Artery Calcification · Coronary Stenosis
Primary: Rate of Change in Total Coronary Calcium Scores by Computed Tomography — 32; 58 Agatston score change
Rheumatoid Arthritis
Primary: Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) Rheumatoid Arthritis Magnetic Resonance Imaging Scoring System (RAMRIS) Synovitis Score — 3.4; 2.3…
Alopecia
Primary: Number of Participants With Any Adverse Events (AEs) and Any Serious Adverse Events (SAEs) — 64; 2 Participants
Breast Cancer
Primary: Percentage of Participants Achieving Complete Response (CR) or Partial Response (PR) According to World Health Organization (WHO) Handbook for Reporting Results of…
Smoking Cessation · Bipolar Disorder
Primary: 7-day Prevalence of Abstinence From Cigarette Smoking at 12 Weeks — 15; 3 participants
Major Cutaneous Abscess · Cellulitis · Erysipelas
Primary: Incidence of Adverse Events (AEs) and Serious Adverse Events (SAEs) — 91 participants
Idiopathic Pulmonary Fibrosis
Primary: Change in Percent Predicted Forced Vital Capacity (%FVC) From Baseline to Week 52 — 16.5; 31.8; 22.7; 9.7 percentage of patients
Glaucoma
Primary: Intraocular Pressure (IOP) — 11.52; 12.83 mmHg (millimeters of mercury)
Purpura, Thrombocytopaenic, Idiopathic
Primary: Number of Participants With Bone Marrow (BM) Fibers of MF Grade 0, 1, 2 and 3 on the European Consensus (EC) Scale at Baseline — 150; 9; 0; 0 Participants
Vitiligo
Primary: Number of Participants With a Decrease in Vitiligo Area Scoring Index (VASI) Score — 0; 0 Participants